UNSPSC 51111640: Masoprocol

This classification denotes a lipooxygenase inhibitor and antioxidant with the molecular formula C18H22O4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 7BO8G1BYQU, chemically known as 1,2-benzenediol, 4,4-(2,3-dimethyl-1,4-butanediyl)bis-, (r*,s*)- but generally known as masoprocol, which bears US NIH Compound Identifier 71398. European Medicines Agency schedules Masoprocol in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08652MIG.

UNSPSC 51111640 Masoprocol is a Commodity code covering a pharmaceutical active ingredient with limited recent state and local procurement activity. State and local governments do not appear to purchase masoprocol directly; the code likely reflects pharmacy benefit management systems, medicaid procurement classifications, or pharmaceutical supply-chain taxonomy rather than goods or services actively solicited through standard RFP, RFQ, IFB, or ITB processes at the state, county, municipal, or school-district level. The code shows no recent opportunities in the available state and local contract database, indicating that masoprocol is either not currently acquired through public procurement channels, purchased through standing pharmaceutical contracts or group purchasing organizations without fresh solicitations, or misattributed to this UNSPSC category in existing records.

Without recent solicitation activity to characterize issuing-body patterns, geographic concentration, or representative opportunities, this code does not present an actionable pursuit avenue for state and local procurement professionals at this time. Vendors in the pharmaceutical or active-ingredient supply chain should monitor whether masoprocol acquisition patterns shift toward direct state or local procurement; until then, activity under this code remains dormant in the state and local market.